Explore the official voice of the IBMS - featuring our statements, white papers, consultation responses, policies, press releases, guidance and member publications
Investing in diagnostic capacity, digital transformation, and a robust biomedical science workforce is essential to delivering faster, more equitable elective care for all
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
